Short answer: there isn’t a single price. The cost to set up a baclofen (Lioresal) manufacturing plant depends on scale, whether you’re making the API or the finished dosage form, location/regulatory requirements, and many other factors.
Here are rough, high-level ballparks to give you an idea (capital expenditure, USD):
- Small GMP API line (roughly 1–5 metric tons/year): about 15–40 million
- Mid-scale API plant (10–100+ tons/year): about 40–120 million
- Large-scale API plant (hundreds of tons/year): about 120–350 million or more
- Finished dosage form plant (tablets/capsules with packaging and QA labs): add a significant amount to the API line cost (often 1.5–2.5x the API-only cost depending on line complexity and automation)
Notes and cost drivers:
- API vs finished dosage form: API plants are cheaper than fully integrated dose-form facilities with packaging, serialization, and extensive quality systems.
- Scale and batch size: larger, continuous processes lower per-unit capex but require more equipment and space.
- Location and regulations: regulatory requirements (FDA, EMA, GMP, environmental controls) and local building costs heavily influence CAPEX.
- Equipment mix: reactors, crystallizers, purification/filtration, drying/cooling, solvent recovery, CIP systems, QA/QC labs, analytical equipment, and cleanroom lines.
- Utilities and environmental: solvent handling, waste treatment, HVAC, water purification, power redundancy, and effluent treatment.
- Validation and commissioning: process validation, IQ/OQ/PQ, GMP documentation, and regulatory filings add meaningful costs.
- Timeline: typically 18–36 months from project kick-off to commercial GMP operation, depending on scope.
If you’d like, I can tailor these estimates better with a few details:
- API only or finished dosage form?
- Target capacity (kg/y or tons/y)?
- Country/region for the plant (regulatory environment, local costs)?
- Turnkey project vs. modular/lease-to-own or a CDMO arrangement?
Also, if your goal is to avoid building a plant, consider contracting with a CDMO or sourcing baclofen API from an established supplier and focusing on development/branding rather than in-house manufacturing.